Physician profile
Frank Cikach
NPI 1679078224
$2,311.18
in general payments reported to CMS, 2019-2025
11 companies · $433 in 2025
The $433 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.18 · 2020: $114 · 2021: $89.46 · 2022: $241 · 2023: $725 · 2024: $620 · 2025: $433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,777.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $735.06 | 2020-2024 | |
| Edwards Lifesciences Corporation | $354.85 | 2021-2024 | |
| Bolton Medical INC | $224.17 | 2025 | Relay Thoracic Stent-Graft With Plus Delivery System, Thoraflex Hybrid, Treo Abdominal Stent-Graft System |
| Helios Cardio INC | $193.50 | 2025 | Cardiamend |
| Davol INC. | $160.73 | 2022 | |
| Corcym INC | $158.68 | 2023 | Perceval |
| Dilon Technologies, INC. | $130.54 | 2023 | Hemoblast Bellows |
| Abbott Laboratories | $117.58 | 2024-2025 | Epic, Thoratec Heartmate 3 Lvas Implant Kit |
| Medtronic USA, INC. | $89.18 | 2019 | |
| Medtronic, INC. | $79.49 | 2022-2024 | Accuvac, Corevalve Evolut R |
| Stryker Corporation | $67.40 | 2022-2024 | Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Cikach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.